Enavate Sciences GP, LLC 13D and 13G filings for CAMP4 Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-23 5:58 pm Sale | 2025-12-19 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,127,360 6.000% | -658,442 (-17.39%) | Filing |
| 2025-09-15 7:08 pm Unchanged | 2025-09-11 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,785,802 8.100% | 0 (Unchanged) | Filing |
| 2024-10-22 4:16 pm Purchase | 2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,785,802 19.400% | 3,785,802 (New Position) | Filing |